JP5654808B2 - Method for evaluating or selecting hair growth regulator - Google Patents

Method for evaluating or selecting hair growth regulator Download PDF

Info

Publication number
JP5654808B2
JP5654808B2 JP2010201838A JP2010201838A JP5654808B2 JP 5654808 B2 JP5654808 B2 JP 5654808B2 JP 2010201838 A JP2010201838 A JP 2010201838A JP 2010201838 A JP2010201838 A JP 2010201838A JP 5654808 B2 JP5654808 B2 JP 5654808B2
Authority
JP
Japan
Prior art keywords
dnajc6
hair growth
hair
expression
expression level
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2010201838A
Other languages
Japanese (ja)
Other versions
JP2012055233A5 (en
JP2012055233A (en
Inventor
安曇 長澤
安曇 長澤
一ノ瀬 進
進 一ノ瀬
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kao Corp
Original Assignee
Kao Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kao Corp filed Critical Kao Corp
Priority to JP2010201838A priority Critical patent/JP5654808B2/en
Priority to US13/821,380 priority patent/US9005898B2/en
Priority to PCT/JP2011/070481 priority patent/WO2012033162A1/en
Priority to EP11823636.3A priority patent/EP2614813B1/en
Priority to CN201180043505.0A priority patent/CN103118661B/en
Publication of JP2012055233A publication Critical patent/JP2012055233A/en
Publication of JP2012055233A5 publication Critical patent/JP2012055233A5/ja
Application granted granted Critical
Publication of JP5654808B2 publication Critical patent/JP5654808B2/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Cosmetics (AREA)

Description

本発明は、毛成長制御剤の評価又は選択方法に関する。   The present invention relates to a method for evaluating or selecting a hair growth regulator.

頭髪や体毛は、生物学的には頭部、胸部、手足等の重要な器官を防護するものである。しかしながら、近年、特に手足等における体毛は、美的外観上無い方が好ましいとする傾向が高まっている。   Biologically, hair or body hair protects important organs such as the head, chest, and limbs. However, in recent years, there is an increasing tendency that hair on limbs and the like is preferably not in terms of aesthetic appearance.

体毛を除去する方法としては、シェーバー、抜毛器等を用いる機械的除去方法、脱毛剤や除毛剤を用いた化学的作用による除去方法が挙げられる。しかしながら、これらの体毛除去方法は、皮膚に対して物理的又は化学的刺激を伴う場合があり、また抑毛作用という点では未だ不十分であるため、一定期間経過後には再び体毛除去処理を行わなければならない。体毛除去処理の軽減化が望まれている。   Examples of the method for removing body hair include a mechanical removal method using a shaver, a hair removal device, and the like, and a removal method by chemical action using a hair removal agent or a hair removal agent. However, these hair removal methods may be accompanied by physical or chemical irritation to the skin and are still insufficient in terms of hair suppression action, so that the hair removal treatment is performed again after a certain period of time. There must be. Reduction of body hair removal processing is desired.

従来、育毛剤又は抑毛剤を評価又は選択する場合、生体の皮膚に塗布するか(特許文献1〜3)、生体外(in vitro)でヒトやマウス若しくはラット、又はブタの毛包の器官培養物に候補物質を投与した後、毛の伸長や毛包の成長の度合いを測定し、その測定結果に基づいて候補物質の育毛又は抑毛作用を評価していた(特許文献4〜7、非特許文献1〜3)。効率や評価の正確性を考えるとin vitroでの試験がより好ましい。しかしin vitroでの毛包の器官培養は、試料となる毛包の入手が困難である場合があること、培養に手間がかかること、毛の伸長や毛包成長が観察されるまでに数日間を要するため評価に時間がかかるなどの問題があった。より効率的に育毛剤又は抑毛剤を評価又は選択するためのin vitroスクリーニング系の開発が求められている。   Conventionally, when evaluating or selecting a hair restorer or a hair suppressant, it is applied to the skin of a living body (Patent Documents 1 to 3), or an in vitro human, mouse, rat, or pig hair follicle organ After administering the candidate substance to the culture, the degree of hair elongation and hair follicle growth was measured, and the hair growth or hair-loss action of the candidate substance was evaluated based on the measurement results (Patent Documents 4 to 7, Non-patent documents 1 to 3). Considering the efficiency and accuracy of evaluation, in vitro tests are more preferable. However, organ culture of hair follicles in vitro may be difficult to obtain sample hair follicles, it takes time to cultivate, and several days before hair growth and hair follicle growth are observed Therefore, there is a problem that it takes time to evaluate. There is a need to develop an in vitro screening system for evaluating or selecting hair restorers or hair suppressants more efficiently.

特許文献7には、ヒト毛嚢に、熱ショックタンパク質HSP−27、HSP−70及びHSP−90が存在すること、毛嚢へのHSP−27抗体の投与により毛髪繊維発育の有意な低減が観察されたこと、HSP−90特異的阻害物質ゲルダナマイシン、又はHSP合成阻害物質であるKNK437の投与により、ヒト毛嚢成育が容量依存的に低減したことが記載されている。しかし、熱ショックタンパク質は種類が多く、その機能も多岐にわたるため、上記の熱ショックタンパク質が毛成長に関与する分子メカニズムは明らかでなく、また他の熱ショックタンパク質が毛成長に関与し得るかどうかを予測することはできなかった。   Patent Document 7 observes that heat shock proteins HSP-27, HSP-70 and HSP-90 are present in human hair follicles, and that hair fiber growth is significantly reduced by administration of HSP-27 antibody to hair follicles. It has been described that the growth of human hair follicles was reduced in a dose-dependent manner by the administration of the HSP-90-specific inhibitor geldanamycin or the HSP synthesis inhibitor KNK437. However, since there are many types of heat shock proteins and their functions are diverse, the molecular mechanism by which the above heat shock proteins are involved in hair growth is not clear, and whether other heat shock proteins can be involved in hair growth. Could not be predicted.

国際公開第03/086331号パンフレットInternational Publication No. 03/086331 Pamphlet 特開2005−206536号公報JP-A-2005-206536 特開2006−008657号公報JP 2006-008657 A 国際公開第2010/016606号パンフレットInternational Publication No. 2010/016606 Pamphlet 特開平11−49647号公報JP 11-49647 A 特開2002−62289号公報JP 2002-62289 A 特許第4189024号Japanese Patent No. 4189024

Jindo et al., The Journal of Dermatology, Vol,20:756-762, 1993.Jindo et al., The Journal of Dermatology, Vol, 20: 756-762, 1993. 宇塚 誠及び▲奏▼沢 千加, 日皮誌, 104(8):979-987, 1994.Makoto Utsuka and Sou Chika Sawa, Nikko Journal, 104 (8): 979-987, 1994. Philpott et al., Journal of Cell Science, 97:463-471, 1990.Philpott et al., Journal of Cell Science, 97: 463-471, 1990.

本発明は、遺伝子の発現を指標とした毛成長制御剤の評価又は選択方法に関する。   The present invention relates to a method for evaluating or selecting a hair growth regulator using gene expression as an index.

本発明者らは、DnaJC6の発現を指標とすることで、毛成長を制御する物質を効率的に評価又は選択できることを見出し、本発明を完成した。   The present inventors have found that a substance that controls hair growth can be efficiently evaluated or selected by using the expression of DnaJC6 as an indicator, and have completed the present invention.

すなわち、本発明は以下を提供する。
1)毛成長制御剤の評価又は選択方法であって、以下:
DnaJC6を発現可能な細胞に試験物質を投与する工程;
当該細胞におけるDnaJC6の発現を測定する工程;及び
当該発現に基づいて当該試験物質の毛成長制御効果を評価する工程、
を包含する、方法。
That is, the present invention provides the following.
1) A method for evaluating or selecting a hair growth regulator, comprising:
Administering a test substance to a cell capable of expressing DnaJC6;
Measuring the expression of DnaJC6 in the cell; and evaluating the hair growth control effect of the test substance based on the expression;
Including the method.

本発明によれば、in vitroで、簡便、迅速に且つ効率よく毛成長制御剤を評価又は選択することができる。   According to the present invention, a hair growth regulator can be evaluated or selected in vitro, simply, quickly and efficiently.

オウレン抽出物及びフナバラソウ抽出物がヒトDnaJC6プロモーター活性に与える影響。n=3、mean±SD。*: P <0.05, ***: P <0.001(non-paired t-test、vs Vehicle)。The effect of Aurelia extract and Beech rose extract on human DnaJC6 promoter activity. n = 3, mean ± SD. *: P <0.05, ***: P <0.001 (non-paired t-test, vs Vehicle). オウレン抽出物及びフナバラソウ抽出物がヒトDnaJC6 mRNA発現に与える影響。n=3、mean±SD。*: P <0.05, **: P <0.01(non-paired t-test、vs Vehicle)。The effect of auren extract and beech rose extract on human DnaJC6 mRNA expression. n = 3, mean ± SD. *: P <0.05, **: P <0.01 (non-paired t-test, vs Vehicle). オウレン抽出物及びフナバラソウ抽出物がヒトDnaJC6タンパク質発現に与える影響。Effect of Auren extract and Beech rose extract on human DnaJC6 protein expression. オウレン抽出物が毛成長に与える影響。A:毛成長の経時観察結果(n=5又は6、mean±SD。*: P <0.05, **: P <0.01, ***: P <0.001(non-paired t-test、vs Vehicle)。B:10日後の培養毛包画像。Effect of Aureen extract on hair growth. A: Observation results of hair growth over time (n = 5 or 6, mean ± SD. *: P <0.05, **: P <0.01, ***: P <0.001 (non-paired t-test, vs Vehicle) B: Cultured hair follicle image after 10 days. フナバラソウ抽出物が毛成長に与える影響。A:毛成長の経時観察結果(n=10〜14、mean±SD。***: P <0.001(non-paired t-test、vs Vehicle)。B:9日後の培養毛包画像。Effect of beech extract on hair growth. A: Observation results of hair growth over time (n = 10-14, mean ± SD. ***: P <0.001 (non-paired t-test, vs Vehicle) B: Cultured follicle image after 9 days.

本発明は、毛成長制御剤の評価又は選択方法を提供する。本方法は、以下:DnaJC6を発現可能な細胞に試験物質を投与する工程;当該細胞におけるDnaJC6の発現を測定する工程;及び、当該発現に基づいて当該試験物質の毛成長制御効果を評価する工程、を包含する。   The present invention provides a method for evaluating or selecting a hair growth regulator. The method includes the following steps: administering a test substance to a cell capable of expressing DnaJC6; measuring the expression of DnaJC6 in the cell; and evaluating a hair growth control effect of the test substance based on the expression .

本明細書において、「毛成長制御」とは、毛または毛包の伸長を促進または抑制する作用、あるいは毛径を増加または減少させる作用を意味する。すなわち、本明細書における「毛成長制御」とは、毛成長の促進及び抑制を含む概念である。   In the present specification, “hair growth control” means an action of promoting or suppressing the elongation of hair or hair follicles, or an action of increasing or decreasing hair diameter. That is, “hair growth control” in the present specification is a concept including promotion and suppression of hair growth.

本明細書において、「DnaJC6」とは、NCBIのデータベース(OMIM)[http://www.ncbi.nlm.nih.gov/sites/entrez?db=omim]にMIM ID *608375として登録されているタンパク質を指す。DnaJC6は、熱ショック蛋白質に分類されるタンパク質である。熱ショック蛋白質には多くのファミリーが存在し、例えば、HSP11O、HSP90、HSP70、HSP60、HSP40、HSP27、HSP1Oのファミリーに大別される。このうち、DnaJC6は、DNAJ/HSP40ファミリーに属する分子シャペロンであると推定されている。   In this specification, “DnaJC6” is registered in the NCBI database (OMIM) [http://www.ncbi.nlm.nih.gov/sites/entrez?db=omim] as MIM ID * 608375. Refers to protein. DnaJC6 is a protein classified as a heat shock protein. There are many families of heat shock proteins, for example, broadly divided into HSP11O, HSP90, HSP70, HSP60, HSP40, HSP27, and HSP1O families. Of these, DnaJC6 is presumed to be a molecular chaperone belonging to the DNAJ / HSP40 family.

本明細書において、「DnaJC6を発現可能な細胞」としては、生来的にDnaJC6遺伝子を有し、これを発現する能力のある細胞、及び外来的にDnaJC6遺伝子を発現可能に導入された細胞が挙げられる。当該細胞は、生体から採取された細胞、または生体から採取された組織や器官に含まれる細胞であってもよく、培養細胞であってもよい。好ましくは、当該細胞は、哺乳動物に由来する。生来的にDnaJC6遺伝子を有し、これを発現する能力のある細胞としては、生体のあらゆる組織に由来する細胞が挙げられるが、好ましくは、哺乳動物から採取された皮膚由来の細胞、例えば、毛髪組織由来の細胞、表皮組織由来の細胞、真皮組織由来の細胞(線維芽細胞等)、及び脳由来の細胞等、ならびにこれらの細胞に由来する細胞培養物、器官培養物等が挙げられる。外来的にDnaJC6遺伝子を発現可能にした細胞は、DnaJC6遺伝子を組み込んだ発現ベクターを任意の哺乳動物細胞に導入し、当該細胞を形質転換させることによって得ることができる。DnaJC6遺伝子を組み込んだ発現ベクターの作製方法及び発現ベクターの哺乳動物細胞への導入方法は、当業者に周知である。   In the present specification, “cells capable of expressing DnaJC6” include cells that inherently have the DnaJC6 gene and have the ability to express it, and cells that have been introduced exogenously to express the DnaJC6 gene. It is done. The cell may be a cell collected from a living body, a cell contained in a tissue or organ collected from a living body, or a cultured cell. Preferably, the cell is derived from a mammal. Cells that naturally have the DnaJC6 gene and are capable of expressing it include cells derived from any tissue of the organism, but preferably cells derived from skin collected from mammals, such as hair Examples include tissue-derived cells, epidermal tissue-derived cells, dermal tissue-derived cells (fibroblasts, etc.), brain-derived cells, and the like, and cell cultures, organ cultures, and the like derived from these cells. A cell in which the DnaJC6 gene can be expressed exogenously can be obtained by introducing an expression vector incorporating the DnaJC6 gene into any mammalian cell and transforming the cell. Methods for producing an expression vector incorporating the DnaJC6 gene and methods for introducing the expression vector into mammalian cells are well known to those skilled in the art.

上記細胞に投与される試験物質としては、毛成長制御剤として使用することを所望する物質であれば、特に制限されず、例えば、動植物、海洋生物、微生物等及びその抽出物;それらに由来する天然成分;合成化合物;ならびにそれらの混合物及び組成物等が挙げられる。   The test substance to be administered to the cells is not particularly limited as long as it is a substance desired to be used as a hair growth regulator, for example, animals and plants, marine organisms, microorganisms and extracts thereof; Natural ingredients; synthetic compounds; and mixtures and compositions thereof.

上記細胞におけるDnaJC6の発現は、DnaJC6タンパク質の発現、又は当該タンパク質をコードするDnaJC6遺伝子若しくはそのmRNAの発現、DnaJC6遺伝子のプロモーターの活性化等を指標として測定することができる。測定は、指標とするパラメータ(例えば、タンパク質発現、遺伝子又はmRNA発現、DnaJC6遺伝子プロモーターの活性化等)の測定方法として当該分野で公知の方法に従って行えばよい。測定方法としては、例えば、RT−PCR、アガロースゲル電気泳動、Real−time RT−PCR、SDS−PAGE、クロマトグラフィー法、免疫学的測定法(例えば、免疫組織化学、ELISA、ウエスタンブロット、免疫沈降等)、比色定量法、蛍光・光学的測定法、質量分析、電子顕微鏡観察等、及びこれらの組み合わせ等が挙げられるが、これらに限定されない。   The expression of DnaJC6 in the cells can be measured using the expression of DnaJC6 protein, the expression of DnaJC6 gene encoding the protein or its mRNA, the activation of the promoter of DnaJC6 gene, etc. as an index. The measurement may be performed according to a method known in the art as a method for measuring parameters used as indicators (for example, protein expression, gene or mRNA expression, DnaJC6 gene promoter activation, etc.). As a measuring method, for example, RT-PCR, agarose gel electrophoresis, Real-time RT-PCR, SDS-PAGE, chromatography method, immunoassay (for example, immunohistochemistry, ELISA, Western blot, immunoprecipitation) Etc.), colorimetric determination method, fluorescence / optical measurement method, mass spectrometry, electron microscope observation, etc., and combinations thereof, but are not limited thereto.

DnaJC6遺伝子プロモーターの活性化を指標にDnaJC6の発現を測定する場合、測定に用いるプロモーターとしては、ヒトDnaJC6プロモーターが好ましい。ヒトDnaJC6プロモーターとしては、配列番号1で示される塩基配列を有するプロモーター、及び配列番号1で示される塩基配列に対して1個〜数個(好ましくは1〜10個、より好ましくは1〜5個)の塩基が置換、欠失、挿入、付加されており、且つ配列番号1で示される塩基配列を有するプロモーターと同様の転写因子に制御されて下流の遺伝子の発現を制御するものが挙げられる。DnaJC6遺伝子プロモーターの活性化の測定は、例えば、当該プロモーターの下流にルシフェラーゼ遺伝子等のマーカー遺伝子を作動可能に連結し、当該マーカー遺伝子の発現(例えば、ルシフェラーゼ活性)を測定すればよい。   When measuring DnaJC6 expression using the activation of the DnaJC6 gene promoter as an index, the promoter used for the measurement is preferably the human DnaJC6 promoter. The human DnaJC6 promoter has one to several (preferably 1 to 10, more preferably 1 to 5) promoters having the base sequence represented by SEQ ID NO: 1 and the base sequence represented by SEQ ID NO: 1. ) Are substituted, deleted, inserted, added, and controlled by a transcription factor similar to the promoter having the base sequence shown in SEQ ID NO: 1 to control the expression of downstream genes. The activation of the DnaJC6 gene promoter may be measured by, for example, operably linking a marker gene such as a luciferase gene downstream of the promoter and measuring the expression of the marker gene (for example, luciferase activity).

上記測定結果に基づいて、試験物質の毛成長制御効果を評価する。評価は、例えば、試験物質投与前後で、又は試験物質添加群と試験物質非添加群若しくは対照物質添加群とを比較することによって行われる。あるいは、評価は、種々の濃度の試験物質間で測定結果を比較することによって行われ得る。DnaJC6の発現に影響を与えた物質を毛成長制御剤として選択することができる。例えば、DnaJC6の発現を低下若しくは阻害させるか、又はDnaJC6の発現上昇を抑制する試験物質は、毛成長抑制剤として選択される。DnaJC6の発現を上昇若しくは促進させるか、又はDnaJC6の発現低下を抑制する試験物質は、毛成長促進剤として選択される。   Based on the measurement results, the hair growth control effect of the test substance is evaluated. The evaluation is performed, for example, before and after administration of the test substance, or by comparing the test substance addition group with the test substance non-addition group or the control substance addition group. Alternatively, the evaluation can be performed by comparing the measurement results between different concentrations of the test substance. A substance that affects the expression of DnaJC6 can be selected as a hair growth regulator. For example, a test substance that decreases or inhibits the expression of DnaJC6 or suppresses the increase in expression of DnaJC6 is selected as a hair growth inhibitor. A test substance that increases or promotes the expression of DnaJC6 or suppresses the decrease in the expression of DnaJC6 is selected as a hair growth promoter.

斯くして得られた毛成長制御剤は、発毛、育毛、除毛、脱毛、発毛抑制等のために使用でき、あるいは発毛剤、育毛剤、除毛剤、脱毛剤、発毛抑制剤等の有効成分となり得る。またあるいは、当該毛成長制御剤を、発毛、育毛、除毛、脱毛、発毛抑制等の毛成長の促進又は抑制を必要とする被験体に投与することにより、その被験体において毛成長を促進又は抑制し、発毛、育毛、除毛、脱毛、発毛抑制等を実現することができる。またあるいは、当該毛成長制御剤は、発毛、育毛、除毛、脱毛、発毛抑制等のための組成物、医薬、医薬部外品、化粧料又は飲食品として、あるいはそれらの製造のために使用することができる。   The hair growth control agent thus obtained can be used for hair growth, hair growth, hair removal, hair removal, hair growth suppression, or the like, or hair growth agents, hair growth agents, hair removal agents, hair removal agents, hair growth inhibition. It can be an active ingredient such as an agent. Alternatively, by administering the hair growth regulator to a subject in need of promoting or suppressing hair growth such as hair growth, hair growth, hair removal, hair removal, hair growth inhibition, etc. Hair growth, hair growth, hair removal, hair removal, hair growth inhibition, etc. can be realized by promoting or suppressing. Alternatively, the hair growth regulator may be used as a composition for hair growth, hair growth, hair removal, hair removal, hair growth suppression, etc., as a medicine, quasi-drug, cosmetic or food and drink, or for their production. Can be used for

以下、実施例を示し、本発明をより具体的に説明する。   EXAMPLES Hereinafter, an Example is shown and this invention is demonstrated more concretely.

実施例1 DnaJC6発現に基づく試験物質の評価
(1)手順
オウレン抽出液の調製
オウレン根(新和物産)40gに50%エタノール水溶液400mLを加え、常温で13日間浸漬した。これをろ過し、オウレン抽出液を得た。このオウレン抽出液を濃縮したところ、その固形分は5.46gであった。抽出液の固形分濃度は1.73wt%であった。
フナバラソウ抽出液の調製
フナバラソウ根(新和物産)40gに50%エタノール水溶液400mLを加え、常温で27日間浸漬した。これをろ過し、フナバラソウ抽出液を得た。このフナバラソウ抽出液を濃縮したところ、その固形分は4.39gであった。抽出液の固形分濃度は1.33wt%であった。
Example 1 Evaluation of Test Substance Based on DnaJC6 Expression (1) Procedure
Preparation of Ouren Extract Solution 400 mL of 50% ethanol aqueous solution was added to 40 g of Ouren root (Shinwa Bussan) and immersed for 13 days at room temperature. This was filtered to obtain an aurene extract. When this auren extract was concentrated, the solid content was 5.46 g. The solid concentration of the extract was 1.73 wt%.
Preparation of Beech Grassroot Extract 400 ml of 50% ethanol aqueous solution was added to 40 g of beech grassroot (Shinwa product) and immersed at room temperature for 27 days. This was filtered to obtain a beech extract. When this beech rose extract was concentrated, the solid content was 4.39 g. The solid content concentration of the extract was 1.33 wt%.

DnaJC6発現が認められるヒト培養細胞(293A、ATCCまたはMeWo、財団法人ヒューマンサイエンス振興財団)を、DMEM(Invitrogen、High glucose、10% heat-inactivated FBS)中37℃、5% CO2条件下で培養した。試験物質を50%エタノールにて1mg/mlの濃度に調製し、0.1vol%(最終濃度1μg/ml)となるように培地に添加した。対照群には、同量の50%エタノール溶液(Vehicle)を培地に添加した。 Cultured human cultured cells (293A, ATCC or MeWo, Human Science Foundation) with DnaJC6 expression in DMEM (Invitrogen, High glucose, 10% heat-inactivated FBS) at 37 ° C, 5% CO 2 did. The test substance was adjusted to a concentration of 1 mg / ml with 50% ethanol and added to the medium so that the concentration was 0.1 vol% (final concentration 1 μg / ml). For the control group, the same amount of 50% ethanol solution (Vehicle) was added to the medium.

ヒトDnaJC6プロモーター活性の測定
ヒトDnaJC6プロモーター(配列番号1:979bp [転写開始点から−771〜+208])の下流にホタルルシフェラーゼ遺伝子が挿入されたhDnaJC6opP/pGL4.10 [luc2]プラスミド、及びトランスフェクション効率の補正を目的としてCMV promoterの下流にウミシイタケルシフェラーゼが導入されたプラスミド(pRL-CMV、Promega)をLipofectAMINE 2000 reagent(Invitrogen)を用いて、293A細胞にトランスフェクションした。その8時間後に培地を交換し、試験物質を添加した。更に24時間後にそれぞれのルシフェラーゼ活性を測定した。
ルシフェラーゼアッセイはDual-Glo Luciferase Assay System(Promega)を用いて行った。培地を除去後、PBSにより2倍希釈したDual-Glo luciferase reagentを加え、攪拌した後、約20分後にホタルルシフェラーゼ活性を測定した。その後、等量のDual-Glo Stop&Glo reagentを加え、攪拌した後にウミシイタケルシフェラーゼ活性を測定した。尚、双方ともルシフェラーゼ活性の測定時間は2秒とした。
全てのDnaJC6プロモーター活性(ホタルルシフェラーゼ活性)はトランスフェクション効率補正のために導入されたウミシイタケルシフェラーゼ活性にて除することで補正した。その後、DnaJC6プロモーター活性阻害率を以下の式にて求め、DnaJC6プロモーター活性を試験物質が何%阻害したかを算出した。
DnaJC6プロモーター活性阻害率(%)
={(溶媒対照添加群−試験物質添加群)/溶媒対照添加群}×100
Measurement of human DnaJC6 promoter activity hDnaJC6opP / pGL4.10 [luc2] plasmid in which a firefly luciferase gene is inserted downstream of the human DnaJC6 promoter (SEQ ID NO: 1979 bp [−771 to +208 from the transcription start site]), and transfection efficiency In order to correct the above, a plasmid (pRL-CMV, Promega) in which Renilla luciferase was introduced downstream of the CMV promoter was transfected into 293A cells using LipofectAMINE 2000 reagent (Invitrogen). After 8 hours, the medium was changed and the test substance was added. Further, after 24 hours, each luciferase activity was measured.
The luciferase assay was performed using Dual-Glo Luciferase Assay System (Promega). After removing the medium, Dual-Glo luciferase reagent diluted 2-fold with PBS was added and stirred, and then firefly luciferase activity was measured about 20 minutes later. Thereafter, an equal amount of Dual-Glo Stop & Glo reagent was added and stirred, and then Renilla luciferase activity was measured. In both cases, the measurement time for luciferase activity was 2 seconds.
All DnaJC6 promoter activities (firefly luciferase activities) were corrected by dividing by the Renilla luciferase activity introduced for transfection efficiency correction. Thereafter, the inhibition rate of DnaJC6 promoter activity was determined by the following formula, and the percentage of the test substance inhibiting DnaJC6 promoter activity was calculated.
DnaJC6 promoter activity inhibition rate (%)
= {(Solvent control addition group-test substance addition group) / solvent control addition group} × 100

Real-time RT-PCR
試験物質を添加後、24時間培養したMeWo細胞からRNeasy Mini Kit(QIAGEN)を用いてtotal RNAを抽出した。total RNAの調製は付属の使用説明書に従って実施した。total RNAは濃度を揃えた後65℃、5分間の熱処理を行い、急冷後に使用した。逆転写反応には、一定量のtotal RNAとOligo(dT)20を用い、ThermoScript RT-PCR System(Invitrogen)を用い、反応は付属の使用説明書に従って実施した。RTサンプルは、使用まで−20℃で保存した。
Real-time RT-PCRによるmRNA発現の定量は、POWER SYBR-green PCR Master Mix(ABI)を用い、PCRプロダクト自動検出/定量システムPRISM7500(ABI)を用いて実施した。50μlの反応液にて、増幅条件は、95℃、15秒の変性反応、60℃、1分のアニーリング及び伸長反応にて行った。DnaJC6 mRNA遺伝子発現量は、コントロール遺伝子RPLP0 mRNA発現量により補正した。RT-PCRに使用したプライマーはPrimer Express ver. 2.0(ABI)を利用して設計した。用いたプライマーを以下に示す。
DnaJC6 Forward: CAGGAAAGTGAGCAATCAGATGA(配列番号2)
DnaJC6 Reverse: GGCTTGTCACCATTGGCATT (NM_014787: 53bp、配列番号3)
RPLP0 Forward: TCCTGAGTGATGTGCAGCTGAT (配列番号4)
RPLP0 Reverse: AGCACTTCAGGGTTGTAGATGCT(NM_053275: 151bp、配列番号5)
Real-time RT-PCR
After adding the test substance, total RNA was extracted from MeWo cells cultured for 24 hours using RNeasy Mini Kit (QIAGEN). Total RNA was prepared according to the attached instruction manual. The total RNA was heat-treated at 65 ° C. for 5 minutes after adjusting the concentration, and used after quenching. For the reverse transcription reaction, a certain amount of total RNA and Oligo (dT) 20 were used, and ThermoScript RT-PCR System (Invitrogen) was used. The reaction was performed according to the attached instruction manual. RT samples were stored at −20 ° C. until use.
Quantification of mRNA expression by Real-time RT-PCR was performed using POWER SYBR-green PCR Master Mix (ABI) and PCR product automatic detection / quantification system PRISM7500 (ABI). In 50 μl of the reaction solution, amplification conditions were 95 ° C., 15 seconds denaturation reaction, 60 ° C., 1 minute annealing and extension reaction. The DnaJC6 mRNA gene expression level was corrected by the control gene RPLP0 mRNA expression level. Primers used for RT-PCR were designed using Primer Express ver. 2.0 (ABI). The primers used are shown below.
DnaJC6 Forward: CAGGAAAGTGAGCAATCAGATGA (SEQ ID NO: 2)
DnaJC6 Reverse: GGCTTGTCACCATTGGCATT (NM_014787: 53bp, SEQ ID NO: 3)
RPLP0 Forward: TCCTGAGTGATGTGCAGCTGAT (SEQ ID NO: 4)
RPLP0 Reverse: AGCACTTCAGGGTTGTAGATGCT (NM_053275: 151bp, SEQ ID NO: 5)

ウェスタンブロッティング
試験物質を添加後、24時間培養したMeWo細胞を回収後、1% protease inhibitor cocktail(SIGMA)を含むLysis buffer(50mM Tris-HCl、125mM NaCl、0.5% NP40、pH=7.6)により可溶化し、Sample bufferと混合後、100℃、5分間熱処理した後にウェスタンブロッティングに用いた。ポリアクリルアミドゲル電気泳動は標準的な方法で行い、4-20% gradient gelを用いた。ブロッティングはウェット法によりHybond P(Amersham)メンブレンに転写した。メンブレンに転写後、5%スキムミルクでブロッキングを行った。一次抗体は、標準的な方法にて作製したrabbit anti-DnaJC6抗体を5%スキムミルク中1μg/mlで、goat anti-beta-Actin(I-19)抗体(SantaCruz)を5%スキムミルク中0.2μg/mlで使用した。二次抗体は、それぞれanti-rabbit IgG-HRP(Amersham)またはanti-goat IgG-HRP(SantaCruz)を用い、5%スキムミルク中1/2000希釈で使用した。ECL発色はLumiGLO Reagent and Peroxide(Cell Signaling)を用い、使用説明書に従って行った。
After adding Western blotting test substances, MeWo cells cultured for 24 hours are collected and solubilized with Lysis buffer (50 mM Tris-HCl, 125 mM NaCl, 0.5% NP40, pH = 7.6) containing 1% protease inhibitor cocktail (SIGMA) After mixing with Sample buffer, it was heat-treated at 100 ° C. for 5 minutes and then used for Western blotting. Polyacrylamide gel electrophoresis was performed by a standard method, and 4-20% gradient gel was used. Blotting was transferred to a Hybond P (Amersham) membrane by a wet method. After transfer to the membrane, blocking was performed with 5% skim milk. The primary antibody was rabbit anti-DnaJC6 antibody prepared by standard methods at 1 μg / ml in 5% skim milk, and goat anti-beta-Actin (I-19) antibody (SantaCruz) in 0.2 μg in 5% skim milk. / Ml. Secondary antibodies were anti-rabbit IgG-HRP (Amersham) or anti-goat IgG-HRP (SantaCruz), respectively, and used at a 1/2000 dilution in 5% skim milk. ECL color development was performed using LumiGLO Reagent and Peroxide (Cell Signaling) according to the instruction manual.

(2)結果
結果を図1、2及び3に示す。対照群(Vehicle)に対してオウレン及びフナバラソウエキスを添加した群では、それぞれDnaJC6プロモーター活性及びDnaJC6 mRNA発現が有意に抑制され、DnaJC6タンパク質発現量も抑制された。
(2) Results The results are shown in FIGS. In the group to which the auren and beech rose extract were added to the control group (Vehicle), DnaJC6 promoter activity and DnaJC6 mRNA expression were significantly suppressed, and the expression level of DnaJC6 protein was also suppressed.

実施例2 ヒト単離毛包を用いた試験物質の抑毛評価
ヒト頭皮サンプルは0.1%ヒビテン液に1分間浸漬して消毒後、PBSにて洗浄した。その後、William E培地(Invitrogen)中、実体顕微鏡下にてピンセットとメスを用いて毛包を単離した。単離した毛包は、William E培地に2mM L-Glutamine(Invitrogen)、10μg/ml Insulin(Invitrogen)、40ng/ml Hydrocortisone(SIGMA)、1% Antibiotics-antimitotics(Invitrogen)となるように添加した培地中(24 well plate、300μl)にて37℃、5% CO2条件下で培養した。実施例1で調製したオウレン抽出液とフナバラソウ抽出液を50%エタノールにて1mg/mlの濃度に調製し、0.1vol%(最終濃度1μg/ml)となるように培地に添加した。対照として、同量の50%エタノール溶液(Vehicle)を培地に添加した。
器官培養毛は、経時的に顕微鏡下で写真を撮影、同条件で撮影されたスケールを元に画像解析にて毛包の長さを算出した。画像解析はNewQube(version 4.0.3、Nexus)により実施し、初期値からの増加量を毛伸長量とした。
Example 2 Evaluation of Barberation of Test Substance Using Human Isolated Hair Follicle A human scalp sample was disinfected by immersing in a 0.1% Hibiten solution for 1 minute and then washed with PBS. Thereafter, hair follicles were isolated in a William E medium (Invitrogen) using tweezers and a scalpel under a stereomicroscope. The isolated hair follicle was added to William E medium so as to be 2 mM L-Glutamine (Invitrogen), 10 μg / ml Insulin (Invitrogen), 40 ng / ml Hydrocortisone (SIGMA), 1% Antibiotics-antimitotics (Invitrogen) Medium (24 well plate, 300 μl) was cultured under conditions of 37 ° C. and 5% CO 2 . The oren extract and the beech rose extract prepared in Example 1 were adjusted to a concentration of 1 mg / ml with 50% ethanol and added to the medium so that the concentration was 0.1 vol% (final concentration 1 μg / ml). As a control, the same amount of 50% ethanol solution (Vehicle) was added to the medium.
For organ-cultured hair, photographs were taken over time under a microscope, and the length of the hair follicle was calculated by image analysis based on the scale photographed under the same conditions. Image analysis was performed with NewQube (version 4.0.3, Nexus), and the amount of increase from the initial value was defined as the amount of hair elongation.

結果を図4及び5に示す。対照群(Vehicle)では、培養時間に従って毛包の伸長(毛成長)が観察された一方、DnaJC6発現抑制作用を有するオウレン又はフナバラソウ添加群では、毛包の伸長が有意に抑制された。   The results are shown in FIGS. In the control group (Vehicle), hair follicle elongation (hair growth) was observed according to the culture time, while in the group added with auren or beech rose having DnaJC6 expression inhibitory action, hair follicle elongation was significantly suppressed.

Claims (5)

下記工程(A)〜(C):
(A)試験物質の存在下及び非存在下でDnaJC6を発現可能な細胞におけるDnaJC6の発現量を測定する工程;
(B)試験物質存在下での当該細胞におけるDnaJC6の発現量と、試験物質非存在下での当該細胞におけるDnaJC6の発現量とを比較する工程;及び
(C)試験物質の非存在下と比べて、DnaJC6の発現量を減少させる試験物質を毛成長抑制剤として選択し、DnaJC6の発現量を増加させる試験物質を毛成長促進剤として選択する工程、
を含む毛成長抑制及び毛成長促進剤の評価又は選択方法。
The following steps (A) to (C):
(A) a step of measuring the expression level of DnaJC6 in cells capable of expressing DnaJC6 in the presence and absence of a test substance;
(B) comparing the expression level of DnaJC6 in the cell in the presence of the test substance with the expression level of DnaJC6 in the cell in the absence of the test substance; and (C) comparing with the absence of the test substance. Selecting a test substance that decreases the expression level of DnaJC6 as a hair growth inhibitor, and selecting a test substance that increases the expression level of DnaJC6 as a hair growth promoter ,
A method for evaluating or selecting a hair growth inhibitor and a hair growth promoter .
前記DnaJC6の発現量が、DnaJC6タンパク質の発現、DnaJC6タンパク質をコードする遺伝子若しくはmRNAの発現、又はDnaJC6タンパク質をコードする遺伝子のプロモーターの活性化の量である、請求項記載の方法。 The expression level of DnaJC6 is, the expression of DnaJC6 protein, expression of a gene or mRNA coding for DnaJC6 protein, or the amount of activation of the promoter of the gene encoding DnaJC6 protein, The method of claim 1, wherein. DnaJC6タンパク質をコードする遺伝子若しくはmRNAの発現量の測定が、ポリメラーゼ連鎖反応(PCR)法、又はNorthern blotting法、又はRNase protection assay法、又はDNAアレイ解析により行われる、請求項記載の方法。 The method according to claim 2 , wherein the expression level of the gene or mRNA encoding the DnaJC6 protein is measured by a polymerase chain reaction (PCR) method, a northern blotting method, an RNase protection assay method, or a DNA array analysis. DnaJC6のタンパク質の発現量の測定が、DnaJC6タンパク質に特異的な抗体を利用するWestern blotting法、ELISA法、又はRIA法により行われる、請求項記載の方法。 The method according to claim 2 , wherein the expression level of the DnaJC6 protein is measured by Western blotting, ELISA, or RIA using an antibody specific for the DnaJC6 protein. 前記DnaJC6の発現量がDnaJC6タンパク質をコードする遺伝子のプロモーターにより制御されるマーカー遺伝子の発現産物の量であり、前記(A)において、前記DnaJC6を発現可能な細胞に当該マーカー遺伝子を予め導入する工程を含む請求項記載の方法。 The expression level of the DnaJC6 is an amount of an expression product of a marker gene controlled by a promoter of a gene encoding the DnaJC6 protein, and the marker gene is previously introduced into a cell capable of expressing the DnaJC6 in (A) the method of claim 1 further comprising.
JP2010201838A 2010-09-09 2010-09-09 Method for evaluating or selecting hair growth regulator Expired - Fee Related JP5654808B2 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
JP2010201838A JP5654808B2 (en) 2010-09-09 2010-09-09 Method for evaluating or selecting hair growth regulator
US13/821,380 US9005898B2 (en) 2010-09-09 2011-09-08 Method for controlling hair growth, method for selecting or evaluating hair growth control agent, and hair growth suppression agent
PCT/JP2011/070481 WO2012033162A1 (en) 2010-09-09 2011-09-08 Method for controlling hair growth, method for selecting or evaluating hair growth control agent, and hair growth suppression agent
EP11823636.3A EP2614813B1 (en) 2010-09-09 2011-09-08 Method for selecting or evaluating hair growth control agent
CN201180043505.0A CN103118661B (en) 2010-09-09 2011-09-08 Hair-growth control method, the evaluation of hair growth controlling agent or system of selection and hair growth inhibitor

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2010201838A JP5654808B2 (en) 2010-09-09 2010-09-09 Method for evaluating or selecting hair growth regulator

Publications (3)

Publication Number Publication Date
JP2012055233A JP2012055233A (en) 2012-03-22
JP2012055233A5 JP2012055233A5 (en) 2014-06-19
JP5654808B2 true JP5654808B2 (en) 2015-01-14

Family

ID=46053099

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010201838A Expired - Fee Related JP5654808B2 (en) 2010-09-09 2010-09-09 Method for evaluating or selecting hair growth regulator

Country Status (1)

Country Link
JP (1) JP5654808B2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9005898B2 (en) * 2010-09-09 2015-04-14 Kao Corporation Method for controlling hair growth, method for selecting or evaluating hair growth control agent, and hair growth suppression agent

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050249685A1 (en) * 2004-04-27 2005-11-10 Natalia Botchkareva Reduction of hair growth
EP1910564A1 (en) * 2005-05-13 2008-04-16 Duke University Gene expression signatures for oncogenic pathway deregulation
US20090203574A1 (en) * 2006-05-31 2009-08-13 Elaine Fuchs Method for Modulating Hair Growth
SG10201404883YA (en) * 2009-08-14 2014-10-30 Berg Llc Vitamin d3 and analogs thereof for treating alopecia

Also Published As

Publication number Publication date
JP2012055233A (en) 2012-03-22

Similar Documents

Publication Publication Date Title
Huh et al. A cell-based system for screening hair growth-promoting agents
Elias et al. EMSY expression affects multiple components of the skin barrier with relevance to atopic dermatitis
Xia et al. Increased CCN2 transcription in keloid fibroblasts requires cooperativity between AP-1 and SMAD binding sites
TWI528034B (en) Screening method of dry skin improving agent due to allergic dermatitis caused by the activity of bleomycin hydrolytic enzyme as an index
JP5654808B2 (en) Method for evaluating or selecting hair growth regulator
Kaufmann et al. The N-terminal splice product NF1-10a-2 of the NF1 gene codes for a transmembrane segment
Geiser et al. Secreted ferritin: mosquito defense against iron overload?
TWI586358B (en) Extraction of bleomycin extract, angelica extract, cork extract, wild sesame extract, rosemary extract, benzenesulfonyl GABA and erythritol for the manufacture of bleomycin hydrolyzate production accelerator
KR20120047864A (en) Methods for screening for anti-graying agents on the basis of aff-4 expression
US20230167498A1 (en) Method of determining the phenotype of a hair follicle
Jeong et al. Rab25 deficiency perturbs epidermal differentiation and skin barrier function in mice
Park et al. Conserved properties of a urochordate estrogen receptor-related receptor (ERR) with mammalian ERRalpha
WO2012033162A1 (en) Method for controlling hair growth, method for selecting or evaluating hair growth control agent, and hair growth suppression agent
Li et al. Biphasic calcium phosphate recruits Tregs to promote bone regeneration
Colitti et al. Functional expression of bcl-2 protein family and AIF in bovine mammary tissue in early lactation
JP2016214085A (en) Hair growth inhibitor evaluation or selection method
Davis et al. Age dependent expression and distribution of nitric oxide (NO) synthase isoforms in the ovine kidney
JP6583704B2 (en) Screening method for pigmentation improvers
JP6061448B2 (en) Test substance evaluation method
JP5548498B2 (en) Method for evaluating external preparation for skin
KR101893387B1 (en) Method for Screening Autophagy Regulator
JP2013192491A (en) Method for evaluating and selecting hair growth-controlling agent
Polkoff et al. LGR5 is a Conserved Marker of Hair Follicle Stem Cells Across Species and is Present Early and Throughout Follicle Morphogenesis
CN118383329A (en) Construction method and application of Lars gene-deleted mitochondrial myopathy mouse model
JP5859359B2 (en) Evaluation method of cooling effect by test sample

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20130618

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20140430

A871 Explanation of circumstances concerning accelerated examination

Free format text: JAPANESE INTERMEDIATE CODE: A871

Effective date: 20140430

A975 Report on accelerated examination

Free format text: JAPANESE INTERMEDIATE CODE: A971005

Effective date: 20140514

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20140610

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20140801

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20141104

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20141121

R151 Written notification of patent or utility model registration

Ref document number: 5654808

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R151

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

LAPS Cancellation because of no payment of annual fees